2021
DOI: 10.1002/jev2.12140
|View full text |Cite
|
Sign up to set email alerts
|

Formation of a protein corona on the surface of extracellular vesicles in blood plasma

Abstract: In this study we tested whether a protein corona is formed around extracellular vesicles (EVs) in blood plasma. We isolated medium‐sized nascent EVs of THP1 cells as well as of Optiprep‐purified platelets, and incubated them in EV‐depleted blood plasma from healthy subjects and from patients with rheumatoid arthritis. EVs were subjected to differential centrifugation, size exclusion chromatography, or density gradient ultracentrifugation followed by mass spectrometry. Plasma protein‐coated EVs had a higher den… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

15
257
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 256 publications
(272 citation statements)
references
References 77 publications
15
257
0
Order By: Relevance
“…As demonstrated for synthetic nanoparticles 48 , EVs are able to recruit on their surface numerous proteins which are present at high concentrations in circulation. The nature of such “protein corona” has recently started to be investigated as for other biogenic nanoparticles 14, 39, 49, 50 . Such investigation promises to disclose new properties of EVs since EV protein corona might be involved in EV-mediated cellular communication or can even provide EVs with new regulatory functions.…”
Section: Discussionmentioning
confidence: 99%
“…As demonstrated for synthetic nanoparticles 48 , EVs are able to recruit on their surface numerous proteins which are present at high concentrations in circulation. The nature of such “protein corona” has recently started to be investigated as for other biogenic nanoparticles 14, 39, 49, 50 . Such investigation promises to disclose new properties of EVs since EV protein corona might be involved in EV-mediated cellular communication or can even provide EVs with new regulatory functions.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have shown that EVs can be 'decorated' with additional proteins besides the canonical exofacial molecules, collectively referred to as 'corona' [46][47][48][49][50][51][52]. Buzas et al [46] showed that EVs associate with extracellular matrix proteins, complement, immunoglobulins, coagulation factors, lipoproteins, nucleic acids, and thiol-reactive antioxidants [46].…”
Section: Evs Cargomentioning
confidence: 99%
“…Buzas et al [46] showed that EVs associate with extracellular matrix proteins, complement, immunoglobulins, coagulation factors, lipoproteins, nucleic acids, and thiol-reactive antioxidants [46]. Furthermore, Toth et al [51] confirmed the interaction between plasma proteins and EVs, and identified a number of proteins (ApoA1, ApoB, ApoC3, ApoE, complement factors 3 and 4B, fibrinogen α-chain, immunoglobulin heavy constant γ2 and γ4 chains) that form a 'corona' around EVs in blood plasma [51].…”
Section: Evs Cargomentioning
confidence: 99%
“…However, some of them can be acquired later in the extracellular space. Accordingly, recent study demonstrated the spontaneous formation of a protein corona around EVs in blood plasma ( Tóth et al, 2021 ). Very likely the acquired proteins impact EV’s properties and activity, which requires further investigation ( Tóth et al, 2021 ).…”
Section: Antigen-specific Antibodies and Light Chains In The Fight To Enhance Extracellular Vesicles Therapeutic Efficacymentioning
confidence: 99%
“…Accordingly, recent study demonstrated the spontaneous formation of a protein corona around EVs in blood plasma ( Tóth et al, 2021 ). Very likely the acquired proteins impact EV’s properties and activity, which requires further investigation ( Tóth et al, 2021 ). Similarly, our observations suggested the ability of EVs to bind freely circulating miRNAs ( Bryniarski et al, 2015 ).…”
Section: Antigen-specific Antibodies and Light Chains In The Fight To Enhance Extracellular Vesicles Therapeutic Efficacymentioning
confidence: 99%